On Wednesday, Alkermes plc (NASDAQ:ALKS) agreed to acquire … This strategic move accelerates Alkermes’ entry into the sleep … Alkermes’ portfolio of orexin 2 receptor agonists, including ALKS 4510 and ALKS … , present, or future patents that could be asserted …

… issue of patent law. Acorda Therapeutics Inc. v. Alkermes PLC, Case … was unenforceable after the patent’s expiration and sought … was unenforceable after the patent’s expiration. However, … without judicial interpretation of patent law. The Federal Circuit …

Alkermes plc (NASDAQ:ALKS) Q1 2025 Earnings Call Transcript May 1, 2025 Alkermes plc misses on … : Good morning. Welcome to the Alkermes Plc conference call to discuss our … for patients and long potential patent lives. This is why the …

… /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for … be accessed by visiting Alkermes' website. About Alkermes plc Alkermes plc is a global … IV" litigation and other patent litigation which may lead to …

… not “arise under” patent law merely because the … underlying dispute involved patent issues; rather jurisdiction follows … (which bars patent royalties after a patent expires) inapplicable … Acorda Therapeutics, Inc. v. Alkermes PLC, 145 F.4th 1299 (Fed …

Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript February 15, 2024 Alkermes plc … morning. Welcome to the Alkermes plc conference call to discuss … relating to VIVITROL’s patent protection, which we … settlement of the VIVITROL patent matter, and most …

… /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for … the Janssen arbitration and VIVITROL patent litigation. Balance Sheet At Dec …  IV" litigation and other patent litigation which may lead to …

Alkermes plc (NASDAQ:ALKS) Q3 2023 Earnings Call Transcript October 25, 2023 Alkermes plc beats … successful settlement of the VIVITROL patent litigation, and the expected completion … with Teva to resolve our patent litigations related to VIVITROL. Under …

… /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for … successful settlement of the VIVITROL® patent litigation, and progress toward completion … , Inc. (Teva) to resolve the patent litigation between the parties related …

… /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for … be accessed by visiting Alkermes' website. About Alkermes plc Alkermes plc is a fully …  IV" litigation and other patent litigation which may lead to …